Seeing Is Believing
Currently out of the existing stock ratings of Julian Harrison, 42 are a BUY (82.35%), 9 are a HOLD (17.65%).
Analyst Julian Harrison, currently employed at BTIG, carries an average stock price target met ratio of 49.33% that have a potential upside of 54.91% achieved within 270 days.
Julian Harrison’s has documented 92 price targets and ratings displayed on 15 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on KROS, Keros Therapeutics at 12-Dec-2024.
Analyst best performing recommendations are on AVTE (AEROVATE THERAPEUTICS).
The best stock recommendation documented was for AVTE (AEROVATE THERAPEUTICS) at 12/6/2022. The price target of $27 was fulfilled within 6 days with a profit of $8.97 (49.75%) receiving and performance score of 82.92.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$80
$26.66 (49.98%)
$80
22 days ago
(03-Jun-2025)
27/32 (84.38%)
$28.94 (56.68%)
284
Buy
$61
$7.66 (14.36%)
$58
3 months 15 days ago
(10-Mar-2025)
10/11 (90.91%)
$5.05 (9.03%)
170
Buy
$57
$3.66 (6.86%)
$53
3 months 21 days ago
(04-Mar-2025)
5/5 (100%)
$18.34 (47.44%)
106
Hold
$67
$13.66 (25.61%)
$51
7 months 3 days ago
(22-Nov-2024)
4/5 (80%)
$20.54 (44.21%)
653
Buy
$35
$-18.34 (-34.38%)
$35
1 years 11 months 22 days ago
(03-Jul-2023)
6/10 (60%)
$12.69 (56.88%)
1001
What Year was the first public recommendation made by Julian Harrison?